Psychiatry and Psychology [F] » Mental Disorders
Description
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. MeSH
Hierarchy View
Subtype Terms (18)
Anxiety Disorders
228 drugs (130 approved, 98 experimental)
Disruptive, Impulse Control, and Conduct Disorders
18 drugs (15 approved, 3 experimental)
Dissociative Disorders
8 drugs (7 approved, 1 experimental)
Feeding and Eating Disorders
60 drugs (43 approved, 17 experimental)
Mood Disorders
82 drugs (55 approved, 27 experimental)
Motor Disorders
1 approved drug
Neurocognitive Disorders
28 drugs (21 approved, 7 experimental)
Neurodevelopmental Disorders
25 drugs (16 approved, 9 experimental)
Neurotic Disorders
3 approved drugs
Personality Disorders
4 approved drugs
Schizophrenia Spectrum and Other Psychotic Disorders
26 drugs (17 approved, 9 experimental)
Sexual Dysfunctions, Psychological
17 drugs (11 approved, 6 experimental)
Sleep Wake Disorders
91 drugs (70 approved, 21 experimental)
Somatoform Disorders
8 drugs (5 approved, 3 experimental)
Substance-Related Disorders
160 drugs (125 approved, 35 experimental)
Trauma and Stressor Related Disorders
3 drugs (1 approved, 2 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (22)
Phase 2 Indicated Drugs (19)
Phase 1 Indicated Drugs (8)
Other Experimental Indicated Drugs (32)
Organization Involved with Phase 4 Indications (129)
Abarbanel Mental Health Center
AGUNCO Obstetrics and Gynecology Centre
Allocated inheritance from Elizabeth Stevn and Niels Rindom, Denmark
Brain & Behavior Research Foundation
Center Abarbanel Mental Health
Centro Clinico Colle Cesarano Tivoli Rome Italy
Centro de Investigación Biomédica en Red (CIBER)
Forensic Psychiatric Institute
Fund for Advancement of Medical Science
German Federal Ministry of Education and Research
Heart and Stroke Foundation of Canada
Hospital de Sant Pau i Santa Tecla de Tarragona
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Medical University of South Carolina
Michael J. Gill Mental Health Clinic
National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Provincial Health Services Authority
Shanghai Municipal Science and Technology Commission
Sleep medicine Centers of Western New York
Stanley Medical Research Institute
State University of New York, Syracuse
The Massachusetts Mental Health Center
The Research Council for Health and Disease, Denmark
Universidad Autonoma de Barcelona
Universidad Nacional de Rosario
University of British Columbia
University of California, Los Angeles
Organization Involved with Phase 3 Indications (55)
Case Western Reserve University
Center for Medicinal Cannabis Research
Christian Medical College, Vellore, India
Clinic for Psychiatric Disorders
Geestelijke gezondheidszorg voor mensen in Eindhoven en omgeving
Johanne and Einar Eilertsen's research fund
Josef and Haldis Andresen's legacy
National Institute of Mental Health and Neuro Sciences, India
Norwegian University of Science and Technology
Scandinavian Society for Psychopharmacology
Shanghai Pudong Nanhui Mental Health Center
Shanghai Xuhui District Mental Health Center
Organization Involved with Phase 2 Indications (57)
International Obsessive-Compulsive Disorder Foundation
Kuhnil Pharmaceutical Co., Ltd.
Methodist Cancer Center, Houston, Texas
National Institute of Neurological Disorders and Stroke (NINDS)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (27)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.